Working to Eradicate Gynecologic Cancers

Helen Mann, MSc

Global Product Statistician
AstraZeneca
Alderley Park
Macclesfield United Kingdom SK10 4TF

Papers:
14 Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multi-study sub-analysis